Platelet Aggregation Devices Market Report 2026

Platelet Aggregation Devices Market Overview

• Platelet Aggregation Devices market size has reached to $1.04 billion in 2025 • Expected to grow to $2.94 billion in 2030 at a compound annual growth rate (CAGR) of 22.5% • Growth Driver: The Increasing Incidence Of Target Diseases Is Driving The Platelet Aggregation Devices Market • Market Trend: Innovative Platelet Pooling Set In The Platelet Aggregation Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Platelet Aggregation Devices Market?

Platelet aggregation devices are specialized instruments used to measure the rate and extent to which platelets clump together, which is crucial for diagnosing and managing disorders related to blood clotting. These devices are used to assess the effectiveness of antiplatelet therapies, diagnose bleeding disorders, and evaluate platelet function in various clinical and research settings. The main type of platelet aggregation devices are reagents, systems, consumables and accessories. Reagents are substances used in laboratory experiments to induce platelet aggregation, which is crucial for diagnosing blood clotting disorders. Each reagent serves a specific purpose, aiding in accurate analysis and treatment planning. The types of channels are four channel, dual channel, and eight channel. The technology used are optical, impedance, others. These are applied by clinical applications, research applications, cardiovascular applications, orthopedic applications, and others. The end users are standalone hospitals, diagnostic laboratories, research and academic institutes and others.

What Is The Platelet Aggregation Devices Market Growth Forecast?

The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.94 billion in 2030 at a compound annual growth rate (CAGR) of 22.5%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing investments in advanced diagnostics, rising demand for rapid platelet function testing, expansion of research in blood disorders, continuous innovation in diagnostic technologies. Major trends in the forecast period include increasing adoption of automated platelet function analyzers, growing demand for high-throughput testing systems, rising integration of digital data management, expansion of multi-channel aggregation devices, enhanced focus on diagnostic accuracy.

Global Platelet Aggregation Devices Market Segmentation

1) By Product: Reagents, Systems, Consumables And Accessories 2) By Channel Configuration: Four Channel, Dual Channel, Eight Channel 3) By Technology: Optical, Impedance, Other Technologies 4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Other Applications 5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users Subsegments: 1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents 2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems 3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

What Is The Driver Of The Platelet Aggregation Devices Market?

The increasing incidence of target diseases is expected to drive the platelet aggregation devices market going forward. Target diseases are specific medical conditions that are the focus of prevention, diagnosis, and treatment efforts due to their significant impact on public health, such as cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices help in decreasing the incidence of target diseases by enabling early detection and effective management of thrombotic risks, thereby preventing complications like heart attacks and strokes in vulnerable populations. For instance, in February 2024, according to statistics published by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), the world saw approximately 20 million new cancer cases and 9.7 million deaths in 2022, with projections indicating a 77% increase to over 35 million new cases by 2050; lung cancer was the most prevalent globally with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Therefore, the increasing incidence of target diseases is driving the growth of the platelet aggregation devices industry.

Key Players In The Global Platelet Aggregation Devices Market

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG And Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, Instrumentation Laboratory

Global Platelet Aggregation Devices Market Trends and Insights

Major companies operating in the platelet aggregation devices market are increasing their focus on developing advanced solutions by launching innovative products such as the first platelet pooling set to help stabilize the U.S. platelet supply and meet growing needs. A platelet pooling set is a specialized medical device used during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, Terumo BCT Inc., a US-based company providing blood components and cellular technology, announced the approval of the IMUGARD WB Platelet Pooling Set by the Food and Drug Administration (FDA), a US-based federal agency. This offers extended shelf life for platelets, FDA clearance for seven-day storage, and enables platelet recoupment from whole blood donations, enhancing flexibility and availability in the platelet aggregation devices market. This launch represents a significant technological advancement by addressing the need for improved platelet availability, more efficient supply management, and supporting strained U.S. platelet supply to meet increasing demand in critical medical procedures like chemotherapy and organ transplants.

What Are Latest Mergers And Acquisitions In The Platelet Aggregation Devices Market?

In August 2023, Cell Microsystems, a US-based bioscience company, acquired Fluxion Biosciences Inc. for an undisclosed amount. This acquisition enhances the platelet aggregation devices market by expanding the product portfolio with IonFlux, BioFlux, and IsoFlux systems, integrating automated patch clamp technology for advanced cellular electrophysiology, and providing innovative tools for live cell assays, rare cell event analysis, and comprehensive platelet aggregation studies. Fluxion Biosciences Inc. is a US-based cell microsystems company that delivers advanced solutions that automate complex assays, including platelet aggregation and thrombus formation.

Regional Outlook

North America was the largest region in the platelet aggregation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Platelet Aggregation Devices Market?

The platelet aggregation devices market consists of revenues earned by entities by providing services such as calibration and maintenance services, device training and education programs, data management and analysis services, remote monitoring and technical support, customization and integration services, and regulatory compliance consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The platelet aggregation devices market also includes sales of products such as laser-based aggregometers, microfluidic devices, biosensor-based aggregation analyzers, point-of-care platelet function analyzers, fluorescence-based aggregation systems, and nanotechnology-enhanced platelet testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.